Corbus Pharmaceuticals Holdings, Inc. valuation and forecast
Explore the models for Corbus Pharmaceuticals Holdings, Inc., adjust their assumptions and compare your own valuation with the platform's.
Stock price today
Loading chart…
Third-party market data · may be delayed
Fair value per share
Under review: data-quality checks not passed.
Price vs value
Under review: data-quality checks not passed. We'll show the comparison once resolved.
Analyst recommendations
Monthly trend
- Oct 202610
- Sep 202610
- Aug 202610
- Jul 202610
Counts of recommendations published by analysts covering Corbus Pharmaceuticals Holdings, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.
Price history
Loading chart…
Third-party market data · may be delayed
CRBP valuation questions
- How does Fundamentalytics value Corbus Pharmaceuticals Holdings, Inc.?
- We use the models that fit Corbus Pharmaceuticals Holdings, Inc.'s business and available financial data: growth cash-flow model. Each model has its own assumptions and data requirements. The calculator explains which models are available and lets you adjust their inputs.
Data: SEC EDGAR filings, retrieved November 1, 2026. Method: how we value companies. Disclosures: research and recommendations disclosure. Back to Corbus Pharmaceuticals Holdings, Inc.